A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19
2021-01-01 Murri, R; Lenkowicz, J; Masciocchi, C; Iacomini, C; Fantoni, M; Damiani, A; Marchetti, A; Sergi, Pda; Arcuri, G; Cesario, A; Patarnello, S; Antonelli, M; Bellantone, R; Bernabei, R; Boccia, S; Calabresi, P; Cambieri, A; Cauda, R; Colosimo, C; Crea, F; De Maria, R; De Stefano, V; Franceschi, F; Gasbarrini, A; Parolini, O; Richeldi, L; Sanguinetti, M; Urbani, A; Zega, M; Scambia, G; Valentini, V; Armuzzi, A; Gremese, E; Gemelli against Covid, Group
Results of the 2nd scientific workshop of the ECCO (IV): Therapeutic strategies to enhance intestinal healing in inflammatory bowel disease
2012-01-01 Armuzzi, A; Van Assche, G; Reinisch, W; de Chambrun, Gp; Griffiths, A; Sladek, M; Preiss, Jc; Lukas, M; D'Haens, G
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases
2018-01-01 Felice, C; Pugliese, D; Papparella, Lg; Pizzolante, F; Onori, E; Gasbarrini, A; Rapaccini, Gl; Guidi, L; Armuzzi, A
Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission
2016-01-01 Palone, F; Vitali, R; Cucchiara, S; Mennini, M; Armuzzi, A; Pugliese, D; Dʼincà, R; Barberio, B; Stronati, L
Intestinal Inflammation is Linked to Hypoacetylation of Histone 3 Lysine 27 and can be Reversed by Valproic Acid Treatment in Inflammatory Bowel Disease Patients
2021-01-01 Felice, C; Lewis, A; Iqbal, S; Gordon, H; Rigoni, A; Colombo, Mp; Armuzzi, A; Feakins, R; Lindsay, Jo; Silver, A
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
2022-01-01 Danese, S; Colombel, Jf; Lukas, M; Gisbert, Jp; D'Haens, G; Hayee, B; Panaccione, R; Kim, Hs; Reinisch, W; Tyrrell, H; Oh, Ys; Tole, S; Chai, A; Chamberlain-James, K; Tang, Mt; Schreiber, S; GARDENIA Study, Group; Armuzzi, A
Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: A parallel group, triple blind, placebo-controlled study
2002-01-01 Cremonini, F; Di Caro, S; Covino, M; Armuzzi, A; Gabrielli, M; Santarelli, L; Nista, Ec; Cammarota, G; Gasbarrini, G; Gasbarrini, A
The Determinants of Out-of-Pocket Expenditure in IBD Italian Patients. Results from the AMICI Survey
2020-01-01 Ruggeri, M; Drago, C; Cadeddu, C; Armuzzi, A; Leone, S; Marchetti, M
Helicobacter pylori treatment: A role for probiotics?
2001-01-01 Cremonini, F; Canducci, F; Di Caro, S; Santarelli, L; Armuzzi, A; Gasbarrini, G; Gasbarrini, A
NOD2 insertion mutation in a Cretan Crohn's disease population - Reply
2003-01-01 Ahmad, T; Orchard, T; Armuzzi, A; Jewell, D; Marshall, S
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease
2008-01-01 Schinzari, F; Armuzzi, A; De Pascalis, B; Mores, N; Tesauro, M; Melina, D; Cardillo, C
Nursing-sensitive outcomes in adult inflammatory bowel disease: A systematic review
2021-01-01 Spagnuolo, R; Corea, A; Napolitano, D; Nisticò, E; Pagnotta, R; Pagliuso, C; Schiavoni, E; Turchini, L; Fiorino, G; Radice, S; Armuzzi, A; Doldo, P
Gender affects C-13-ketoisocaproic acid breath test
2007-01-01 Candelli, M; Armuzzi, A; Miele, L; Nista, Ec; Pignataro, G; Dal Verme, Lz; Grieco, A; Gasbarrini, G; Gasbarrini, A
Diagnostic interobserver variability in Crohn's disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group
2021-01-01 Leoncini, G; Donato, F; Reggiani-Bonetti, L; Salviato, T; Cadei, M; Daperno, M; Principi, Mb; Armuzzi, A; Caprioli, F; Canavese, G; Villanacci, V; IG-IBD Pathology, Group
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy
2021-01-01 Chiappetta, Mf; Viola, A; Mastronardi, M; Turchini, L; Carparelli, S; Orlando, A; Biscaglia, G; Miranda, A; Guida, L; Costantino, G; Scaldaferri, F; Bossa, F; Renna, S; Cappello, M; Alibrandi, A; Orlando, A; Armuzzi, A; Fries, W
The evolution of IBD perceived engagement and care needs across the life-cycle: a scoping review
2021-01-01 Volpato, E; Bosio, C; Previtali, E; Leone, S; Armuzzi, A; Pagnini, F; Graffigna, G
C-13-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation
2004-01-01 Candelli, M; Armuzzi, A; Nista, Ec; Fini, L; Gasbarrini, G; Gasbarrini, A
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
2021-01-01 Privitera, G; Pugliese, D; Lopetuso, Lr; Scaldaferri, F; Neri, M; Guidi, L; Gasbarrini, A; Armuzzi, A
Therapeutic Role of Appendectomy in Ulcerative Colitis: A Tangible Perspective?
2019-01-01 Felice, C; Armuzzi, A
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy
2022-01-01 Tursi, A; Mocci, G; Allegretta, L; Aragona, G; Bianco, Ma; Colucci, R; Cuomo, A; Della Valle, N; Ferronato, A; Forti, G; Gaiani, F; Graziani, Mg; Lorenzetti, R; Luzza, F; Paese, P; Penna, A; Pica, R; Pranzo, G; Rodinò, S; Scarcelli, A; Zampaletta, C; Brozzi, L; Cicerone, C; Cocco, A; De' Angelis, G; Donnarumma, L; Fiorella, S; Iannelli, C; Larussa, T; Le Grazie, M; Luppino, I; Meucci, C; Faggiani, R; Pagnini, C; Perazzo, P; Rodriguez-Castro, Ki; Sacco, R; Sebkova, L; Serio, M; De Monti, A; Picchio, M; Napolitano, D; Schiavoni, E; Turchini, L; Scaldaferri, F; Pugliese, D; Guidi, L; Laterza, L; Privitera, G; Pizzoferrato, M; Lopetuso, Lr; Armuzzi, A; Elisei, W; Maconi, G; Papa, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 | 1-gen-2021 | Murri, R; Lenkowicz, J; Masciocchi, C; Iacomini, C; Fantoni, M; Damiani, A; Marchetti, A; Sergi, Pda; Arcuri, G; Cesario, A; Patarnello, S; Antonelli, M; Bellantone, R; Bernabei, R; Boccia, S; Calabresi, P; Cambieri, A; Cauda, R; Colosimo, C; Crea, F; De Maria, R; De Stefano, V; Franceschi, F; Gasbarrini, A; Parolini, O; Richeldi, L; Sanguinetti, M; Urbani, A; Zega, M; Scambia, G; Valentini, V; Armuzzi, A; Gremese, E; Gemelli against Covid, Group | |
| Results of the 2nd scientific workshop of the ECCO (IV): Therapeutic strategies to enhance intestinal healing in inflammatory bowel disease | 1-gen-2012 | Armuzzi, A; Van Assche, G; Reinisch, W; de Chambrun, Gp; Griffiths, A; Sladek, M; Preiss, Jc; Lukas, M; D'Haens, G | |
| Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases | 1-gen-2018 | Felice, C; Pugliese, D; Papparella, Lg; Pizzolante, F; Onori, E; Gasbarrini, A; Rapaccini, Gl; Guidi, L; Armuzzi, A | |
| Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission | 1-gen-2016 | Palone, F; Vitali, R; Cucchiara, S; Mennini, M; Armuzzi, A; Pugliese, D; Dʼincà, R; Barberio, B; Stronati, L | |
| Intestinal Inflammation is Linked to Hypoacetylation of Histone 3 Lysine 27 and can be Reversed by Valproic Acid Treatment in Inflammatory Bowel Disease Patients | 1-gen-2021 | Felice, C; Lewis, A; Iqbal, S; Gordon, H; Rigoni, A; Colombo, Mp; Armuzzi, A; Feakins, R; Lindsay, Jo; Silver, A | |
| Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study | 1-gen-2022 | Danese, S; Colombel, Jf; Lukas, M; Gisbert, Jp; D'Haens, G; Hayee, B; Panaccione, R; Kim, Hs; Reinisch, W; Tyrrell, H; Oh, Ys; Tole, S; Chai, A; Chamberlain-James, K; Tang, Mt; Schreiber, S; GARDENIA Study, Group; Armuzzi, A | |
| Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: A parallel group, triple blind, placebo-controlled study | 1-gen-2002 | Cremonini, F; Di Caro, S; Covino, M; Armuzzi, A; Gabrielli, M; Santarelli, L; Nista, Ec; Cammarota, G; Gasbarrini, G; Gasbarrini, A | |
| The Determinants of Out-of-Pocket Expenditure in IBD Italian Patients. Results from the AMICI Survey | 1-gen-2020 | Ruggeri, M; Drago, C; Cadeddu, C; Armuzzi, A; Leone, S; Marchetti, M | |
| Helicobacter pylori treatment: A role for probiotics? | 1-gen-2001 | Cremonini, F; Canducci, F; Di Caro, S; Santarelli, L; Armuzzi, A; Gasbarrini, G; Gasbarrini, A | |
| NOD2 insertion mutation in a Cretan Crohn's disease population - Reply | 1-gen-2003 | Ahmad, T; Orchard, T; Armuzzi, A; Jewell, D; Marshall, S | |
| Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease | 1-gen-2008 | Schinzari, F; Armuzzi, A; De Pascalis, B; Mores, N; Tesauro, M; Melina, D; Cardillo, C | |
| Nursing-sensitive outcomes in adult inflammatory bowel disease: A systematic review | 1-gen-2021 | Spagnuolo, R; Corea, A; Napolitano, D; Nisticò, E; Pagnotta, R; Pagliuso, C; Schiavoni, E; Turchini, L; Fiorino, G; Radice, S; Armuzzi, A; Doldo, P | |
| Gender affects C-13-ketoisocaproic acid breath test | 1-gen-2007 | Candelli, M; Armuzzi, A; Miele, L; Nista, Ec; Pignataro, G; Dal Verme, Lz; Grieco, A; Gasbarrini, G; Gasbarrini, A | |
| Diagnostic interobserver variability in Crohn's disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group | 1-gen-2021 | Leoncini, G; Donato, F; Reggiani-Bonetti, L; Salviato, T; Cadei, M; Daperno, M; Principi, Mb; Armuzzi, A; Caprioli, F; Canavese, G; Villanacci, V; IG-IBD Pathology, Group | |
| One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy | 1-gen-2021 | Chiappetta, Mf; Viola, A; Mastronardi, M; Turchini, L; Carparelli, S; Orlando, A; Biscaglia, G; Miranda, A; Guida, L; Costantino, G; Scaldaferri, F; Bossa, F; Renna, S; Cappello, M; Alibrandi, A; Orlando, A; Armuzzi, A; Fries, W | |
| The evolution of IBD perceived engagement and care needs across the life-cycle: a scoping review | 1-gen-2021 | Volpato, E; Bosio, C; Previtali, E; Leone, S; Armuzzi, A; Pagnini, F; Graffigna, G | |
| C-13-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation | 1-gen-2004 | Candelli, M; Armuzzi, A; Nista, Ec; Fini, L; Gasbarrini, G; Gasbarrini, A | |
| Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches | 1-gen-2021 | Privitera, G; Pugliese, D; Lopetuso, Lr; Scaldaferri, F; Neri, M; Guidi, L; Gasbarrini, A; Armuzzi, A | |
| Therapeutic Role of Appendectomy in Ulcerative Colitis: A Tangible Perspective? | 1-gen-2019 | Felice, C; Armuzzi, A | |
| Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy | 1-gen-2022 | Tursi, A; Mocci, G; Allegretta, L; Aragona, G; Bianco, Ma; Colucci, R; Cuomo, A; Della Valle, N; Ferronato, A; Forti, G; Gaiani, F; Graziani, Mg; Lorenzetti, R; Luzza, F; Paese, P; Penna, A; Pica, R; Pranzo, G; Rodinò, S; Scarcelli, A; Zampaletta, C; Brozzi, L; Cicerone, C; Cocco, A; De' Angelis, G; Donnarumma, L; Fiorella, S; Iannelli, C; Larussa, T; Le Grazie, M; Luppino, I; Meucci, C; Faggiani, R; Pagnini, C; Perazzo, P; Rodriguez-Castro, Ki; Sacco, R; Sebkova, L; Serio, M; De Monti, A; Picchio, M; Napolitano, D; Schiavoni, E; Turchini, L; Scaldaferri, F; Pugliese, D; Guidi, L; Laterza, L; Privitera, G; Pizzoferrato, M; Lopetuso, Lr; Armuzzi, A; Elisei, W; Maconi, G; Papa, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891